Home > Press > CMU Dendron Based Agents May Treat Breast Cancer, Osteoporosis
The study of nanosize particles as drug delivery agents to treat breast cancer and osteoporosis may help millions of U.S. women.
CMU Dendron Based Agents May Treat Breast Cancer, Osteoporosis
Mount Pleasant, MI | March 16, 2005
Central Michigan University faculty chemist Choon Young Lee may help more than 120,000 U.S. women who are diagnosed with breast cancer each year. In addition, her work may improve the lives of 10 million Americans with osteoporosis, mostly women, and the 34 million more who have low bone mass. Osteoporosis is a progressive disease that causes bones to become thin and porous, increasing the risk for fractures.
“The investigation of new agents to treat breast cancer and osteoporosis are the foundation of effective treatment methods,” said Lee.
Both breast cancer and osteoporosis are closely related to estrogen function, and half of all breast cancers are hormone dependent.
Lee’s work is involved with biologically linking estrogen to dendrons — pie-shaped dendrimers — to help provide a foundation for new treatment methods. Dendrimers, three-dimensional particles so small they allow the creation of new structures, literally atom-by-atom, have applications in biotechnology, pharmaceuticals, clothing, electronics and more.
Lee will submit a library of possible steroidal, dendron-modified estradiols (an estrogen) as therapeutic agents for screening by the National Cancer Institute for potential benefits in treating hormone-dependent breast cancer and osteoporosis.
The current non-steroidal treatments for breast cancer and osteoporosis have high rates of side effects. By using dendron-based steroidal agents, a higher potency of the drug could be delivered at a lower dose with few or no side effects to patients.
“A higher potency means that a lower dose of the agent is needed to induce the same effect,” said Lee. “An ideal agent to prevent and treat both osteoporosis and breast cancer should stimulate estrogen receptors in the bone tissue and block them in breast tissue so a tumor would stop growing.
Choon works with undergraduate students, giving them hands-on experience with an emerging field of study.
Lee’s work is supported by a $25,000 CMU research grant.
Choon Young Lee
Copyright © Central Michigan University
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014
Researchers discern the shapes of high-order Brownian motions November 17th, 2014
VDMA Electronics Production Equipment: Growth track for 2014 and 2015 confirmed: Business climate survey shows robust industry sector November 14th, 2014
Open Materials Development Will Be Key for HP's Success in 3D Printing: HP can make a big splash in 3D printing, but it needs to shore up technology claims and avoid the temptation of the razor/razor blade business model in order to flourish November 11th, 2014
Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014
Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014
Unraveling the light of fireflies December 17th, 2014
First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014
Atom-thick CCD could capture images: Rice University scientists develop two-dimensional, light-sensitive material December 20th, 2014
Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014
Instant-start computers possible with new breakthrough December 19th, 2014
Aculon Hires New Business Development Director December 19th, 2014